NYSE: IIPRInnovative Industrial Properties Inc Stock
$50.15+0.04 (+0.08%)
Updated Oct 31, 2025
IIPR Price
$50.15
Fair Value Price
N/A
Market Cap
$1.41B
52 Week Low
$45.44
52 Week High
$134.31
P/E
10.74x
P/B
0.75x
P/S
5.36x
PEG
N/A
Dividend Yield
15.15%
Revenue
$287.88M
Earnings
$137.34M
Gross Margin
89.9%
Operating Margin
53.93%
Profit Margin
46.7%
Debt to Equity
0.23
Operating Cash Flow
$225M
Beta
1.2
Next Earnings
Nov 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
IIPR Overview
Innovative Industrial Properties (REIT) leases to cannabis facilities to state-licensed operators. The company owns 103 properties (7.7 million rentable square feet, including approximately 2.5 million rentable square feet under development/redevelopment) in Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, New York, North Dakota, Ohio, Pennsylvania, Texas, Virginia, and Washington. Innovative Industrial Propertie was founded in 2016 and is headquartered in Park City, UT.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IIPR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Industrial REIT
Industry Rating
F
IIPR
Ranked#9 of 17
Ranked#9 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.28 | C | |
| $56.01 | C | |
| $57.13 | C |
Be the first to know about important IIPR news, forecast changes, insider trades & much more!
IIPR News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IIPR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IIPR is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IIPR is good value based on its earnings relative to its share price (10.74x), compared to the US market average (41.65x)
P/E vs Market Valuation
IIPR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more IIPR due diligence checks available for Premium users.
Valuation
IIPR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
10.74x
Industry
28.38x
Market
41.65x
IIPR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IIPR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
IIPR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.75x
Industry
2.16x
IIPR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IIPR's financial health
Profit margin
Revenue
$62.9M
Net Income
$26.0M
Profit Margin
40%
IIPR's Earnings (EBIT) of $155.25M... subscribe to Premium to read more.
Interest Coverage Financials
IIPR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.3B
Liabilities
$424.6M
Debt to equity
0.23
IIPR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IIPR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$48.4M
Investing
-$5.8M
Financing
-$71.0M
IIPR's operating cash flow ($225.37M)... subscribe to Premium to read more.
Debt Coverage Financials
IIPR vs Industrial REIT Stocks
Innovative Industrial Properties Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.